Purpose: Acid-related disorders, including GERD, peptic ulcer disease, functional dyspepsia, and acid reflux, represent one of the largest and most commercially established segments in gastroenterology. High global prevalence, lifestyle-related risk factors, and chronic symptom recurrence drive sustained demand for both prescription and over-the-counter therapies.
Upload here: https://gastroenterology-hepatology.utilitarianevents.com/upload-presentation/
WhatsApp: https://wa.me/+971551792927
Email: info-ucg@utilitarianconferences.com
Keynote Points:
Extremely large global patient base with recurrent symptoms
Strong dependence on long-term medication use
Dominance of PPIs, H2 blockers, antacids, and combination therapies
Robust OTC market with strong consumer brand recognition
Growth of minimally invasive anti-reflux endoscopic procedures
Lifestyle, diet, and digital symptom-tracking integrations
High competition encouraging differentiation through innovation and branding
Benefits:
Massive, stable, and predictable market demand
High recurring revenue from chronic therapy and self-care products
Strong cross-selling opportunities with lifestyle and wellness solutions
Scalable global distribution across retail, pharmacy, and digital channels
High ROI supported by volume-driven sales
Ideal entry point for emerging GI brands and product extensions